SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-236510
Filing Date
2022-09-01
Accepted
2022-09-01 16:07:52
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d350609ddefa14a.htm DEFA14A 11562
2 GRAPHIC g350609g45u24.jpg GRAPHIC 278614
3 GRAPHIC g350609g46y52.jpg GRAPHIC 114265
  Complete submission text file 0001193125-22-236510.txt   553823
Mailing Address 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET CAMBRIDGE MA 02142 617-949-5200
TCR2 THERAPEUTICS INC. (Filer) CIK: 0001750019 (see all company filings)

IRS No.: 474152751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38811 | Film No.: 221221046
SIC: 2836 Biological Products, (No Diagnostic Substances)